Aerosol-Generating Procedures and Virus Transmission.

Respir Care

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, Tennessee.

Published: August 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

During the early phase of the COVID-19 pandemic, many respiratory therapies were classified as aerosol-generating procedures. This categorization resulted in a broad range of clinical concerns and a shortage of essential medical resources for some patients. In the past 2 years, many studies have assessed the transmission risk posed by various respiratory care procedures. These studies are discussed in this narrative review, with recommendations for mitigating transmission risk based on the current evidence.

Download full-text PDF

Source
http://dx.doi.org/10.4187/respcare.10160DOI Listing

Publication Analysis

Top Keywords

aerosol-generating procedures
8
transmission risk
8
procedures virus
4
virus transmission
4
transmission early
4
early phase
4
phase covid-19
4
covid-19 pandemic
4
pandemic respiratory
4
respiratory therapies
4

Similar Publications

The COVID-19 pandemic severely disrupted postgraduate (PG) teaching in periodontology, affecting academic learning, clinical training, and research productivity. While online education enhanced theoretical knowledge, restrictions on aerosol-generating procedures limited hands-on experience, especially in surgical training and implantology. A cross-sectional survey among PG students and faculty highlighted decreased clinical exposure, reduced research opportunities, and increased trainee stress.

View Article and Find Full Text PDF

Introduction CariesCare International (CCI) is a practice-friendly, health outcomes-focused, patient-centred, risk-based approach to caries management designed for the practice. The unfeasibility of a randomised clinical trial and of aerosol generating procedures (AGPs) during the COVID-19 pandemic to test the caries control effectiveness of CCI shifted it to a non-AGP, reduced on-site consultation, single-interventional study.Aim This 12-month, multicentre, single-group, interventional study aimed at primarily assessing the control of caries progression of a pandemic CCI-adapted protocol in children.

View Article and Find Full Text PDF

Context In the early months of the COVID-19 pandemic, polymerase chain reaction (PCR) testing for SARS-CoV-2 was difficult to obtain and took several days to return a result. Our health system wished to explore the use of the Quidel Sofia (Quidel Corporation, San Diego, CA) antigen test to diagnose COVID-19 in our primary care clinics, but the test was approved for emergency use authorization by the US Food and Drug Administration (FDA) with only 250 test subjects. In addition, because it was important to avoid aerosol-generating procedures in primary care clinics, it was necessary to test the diagnostic performance of the antigen test using mid-turbinate (MT) swabs rather than the approved nasopharyngeal (NP) swab technique.

View Article and Find Full Text PDF

Objective: Surgical treatment of recurrent respiratory papillomatosis (RRP) has been shown to aerosolize human papillomavirus (HPV), putting healthcare workers at risk for exposure, infection, and disease. Knowledge of HPV infection risk among otolaryngologists who treat HPV-related diseases is limited. We sought to characterize the prevalence of oral HPV infection in otolaryngologists treating RRP.

View Article and Find Full Text PDF